Verdence Capital Advisors LLC Sells 5,481 Shares of Cardinal Health, Inc. (NYSE:CAH)

Verdence Capital Advisors LLC decreased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 19.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,919 shares of the company’s stock after selling 5,481 shares during the quarter. Verdence Capital Advisors LLC’s holdings in Cardinal Health were worth $2,711,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of CAH. Rothschild Investment LLC lifted its holdings in Cardinal Health by 10.1% in the fourth quarter. Rothschild Investment LLC now owns 858 shares of the company’s stock valued at $101,000 after buying an additional 79 shares during the period. Private Trust Co. NA lifted its holdings in Cardinal Health by 11.0% in the fourth quarter. Private Trust Co. NA now owns 930 shares of the company’s stock valued at $110,000 after buying an additional 92 shares during the period. Checchi Capital Advisers LLC lifted its holdings in Cardinal Health by 2.7% in the fourth quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company’s stock valued at $411,000 after buying an additional 93 shares during the period. MWA Asset Management lifted its holdings in Cardinal Health by 2.9% in the fourth quarter. MWA Asset Management now owns 3,324 shares of the company’s stock valued at $393,000 after buying an additional 95 shares during the period. Finally, Transcend Capital Advisors LLC lifted its holdings in Cardinal Health by 3.6% in the fourth quarter. Transcend Capital Advisors LLC now owns 2,735 shares of the company’s stock valued at $323,000 after buying an additional 96 shares during the period. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Down 2.2 %

CAH opened at $126.38 on Wednesday. The company has a 50 day moving average of $125.11 and a 200 day moving average of $118.51. The company has a market cap of $30.53 billion, a PE ratio of 23.58, a price-to-earnings-growth ratio of 1.49 and a beta of 0.63. Cardinal Health, Inc. has a 12 month low of $93.17 and a 12 month high of $132.84.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.60%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s dividend payout ratio is presently 37.69%.

Wall Street Analyst Weigh In

CAH has been the topic of several research reports. Argus set a $148.00 price objective on shares of Cardinal Health in a report on Tuesday, February 4th. Wells Fargo & Company upped their price objective on shares of Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. JPMorgan Chase & Co. upped their price objective on shares of Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. Mizuho began coverage on shares of Cardinal Health in a report on Wednesday, December 4th. They set an “outperform” rating and a $139.00 price objective on the stock. Finally, Citigroup upped their target price on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a report on Friday, January 10th. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and a consensus price target of $139.36.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.